These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36761410)

  • 21. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis.
    Forgrave LM; Ma M; Best JR; DeMarco ML
    Alzheimers Dement (Amst); 2019 Dec; 11():730-743. PubMed ID: 31909174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neurofilament light chain level as a predictor of cognitive stage transition.
    Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
    Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
    Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
    Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
    Sánchez-Valle R; Heslegrave A; Foiani MS; Bosch B; Antonell A; Balasa M; Lladó A; Zetterberg H; Fox NC
    Alzheimers Res Ther; 2018 Nov; 10(1):113. PubMed ID: 30390718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Neurofilament Light and Future Declines in Cognition and Function in Alzheimer's Disease in the FIT-AD Trial.
    Li D; Zhang L; Nelson NW; Mielke MM; Yu F
    J Alzheimers Dis Rep; 2021; 5(1):601-611. PubMed ID: 34514342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet.
    Oh U; Woolbright E; Lehner-Gulotta D; Coleman R; Conaway M; Goldman MD; Brenton JN
    Mult Scler Relat Disord; 2023 May; 73():104670. PubMed ID: 36996634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
    Hoffmann K; Sobol NA; Frederiksen KS; Beyer N; Vogel A; Vestergaard K; Brændgaard H; Gottrup H; Lolk A; Wermuth L; Jacobsen S; Laugesen LP; Gergelyffy RG; Høgh P; Bjerregaard E; Andersen BB; Siersma V; Johannsen P; Cotman CW; Waldemar G; Hasselbalch SG
    J Alzheimers Dis; 2016; 50(2):443-53. PubMed ID: 26682695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease.
    Yao W; Zhang X; Zhao H; Xu Y; Bai F;
    J Alzheimers Dis; 2022; 89(2):505-518. PubMed ID: 35871350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease.
    Frederiksen KS; Madsen K; Andersen BB; Beyer N; Garde E; Høgh P; Waldemar G; Hasselbalch SG; Law I
    Alzheimers Dement (N Y); 2019; 5():208-215. PubMed ID: 31198839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia.
    Lim B; Grøntvedt GR; Bathala P; Kale SS; Campbell CT; Stengelin M; Sando SB; Prassas I; Diamandis EP; Bråthen G
    Neurobiol Aging; 2021 Nov; 107():78-85. PubMed ID: 34403936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease.
    Dhiman K; Gupta VB; Villemagne VL; Eratne D; Graham PL; Fowler C; Bourgeat P; Li QX; Collins S; Bush AI; Rowe CC; Masters CL; Ames D; Hone E; Blennow K; Zetterberg H; Martins RN
    Alzheimers Dement (Amst); 2020; 12(1):e12005. PubMed ID: 32211500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleó A; Johannsen P; Freund-Levi Y; Frölich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
    Alzheimers Dement; 2019 May; 15(5):644-654. PubMed ID: 30853464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults.
    Hu H; Chen KL; Ou YN; Cao XP; Chen SD; Cui M; Dong Q; Tan L; Yu JT;
    Aging (Albany NY); 2019 Sep; 11(17):6904-6914. PubMed ID: 31514172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    Yu F; Vock DM; Zhang L; Salisbury D; Nelson NW; Chow LS; Smith G; Barclay TR; Dysken M; Wyman JF
    J Alzheimers Dis; 2021; 80(1):233-244. PubMed ID: 33523004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic Effects of Aerobic Exercise in Alzheimer's Disease: Imaging Findings From the Pilot FIT-AD Trial.
    Yu F; Mathiason MA; Han S; Gunter JL; Jones D; Botha H; Jack C
    Front Aging Neurosci; 2021; 13():703691. PubMed ID: 34690736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.
    Sobol NA; Hoffmann K; Frederiksen KS; Vogel A; Vestergaard K; Brændgaard H; Gottrup H; Lolk A; Wermuth L; Jakobsen S; Laugesen L; Gergelyffy R; Høgh P; Bjerregaard E; Siersma V; Andersen BB; Johannsen P; Waldemar G; Hasselbalch SG; Beyer N
    Alzheimers Dement; 2016 Dec; 12(12):1207-1215. PubMed ID: 27344641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.